Abstract
Chitinases belong to family 18 glycosyl hydrolases that can hydrolyze chitin by cleaving β-1,4-glycosidic bond, and are at key points in the life cycles of organism. The inhibitors of chitinases not only have chemotherapeutic potential against fungi, insects, but also hold anti-inflammatory efficacy against asthma and allergic disease in human. This review summarizes the structural characters of chitinases, the proposed catalytic mechanism, furthermore, also gives descriptions of currently existing inhibitors. In addition, computational studies of the interaction modes of chitinases with different inhibitors and substrates, as well as the inhibitor design of chitinases, are summarized so as to obtain an overall understanding for chitinases.
Keywords: Chitinases, chitinase inhibitors, computer-aided approach, homopolymer, glycosyl hydrolases, mammals, homology, docking, virtual screening, drug design
Current Drug Targets
Title: Investigation of Family 18 Chitinases and Inhibitors by Computer-Aided Approaches
Volume: 13 Issue: 4
Author(s): Huiying Chu, Jinan Wang, Hujun Shen, Yongliang Yang, Weiliang Zhu and Guohui Li
Affiliation:
Keywords: Chitinases, chitinase inhibitors, computer-aided approach, homopolymer, glycosyl hydrolases, mammals, homology, docking, virtual screening, drug design
Abstract: Chitinases belong to family 18 glycosyl hydrolases that can hydrolyze chitin by cleaving β-1,4-glycosidic bond, and are at key points in the life cycles of organism. The inhibitors of chitinases not only have chemotherapeutic potential against fungi, insects, but also hold anti-inflammatory efficacy against asthma and allergic disease in human. This review summarizes the structural characters of chitinases, the proposed catalytic mechanism, furthermore, also gives descriptions of currently existing inhibitors. In addition, computational studies of the interaction modes of chitinases with different inhibitors and substrates, as well as the inhibitor design of chitinases, are summarized so as to obtain an overall understanding for chitinases.
Export Options
About this article
Cite this article as:
Chu Huiying, Wang Jinan, Shen Hujun, Yang Yongliang, Zhu Weiliang and Li Guohui, Investigation of Family 18 Chitinases and Inhibitors by Computer-Aided Approaches, Current Drug Targets 2012; 13 (4) . https://dx.doi.org/10.2174/138945012799499695
DOI https://dx.doi.org/10.2174/138945012799499695 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacokinetic Considerations of Inhaled Pharmaceuticals for Systemic Delivery
Current Pharmaceutical Design Rational Pharmacotherapy and Pharmacovigilance
Current Drug Safety Treatment Options for Cystic Fibrosis: State of the Art and Future Perspectives
Reviews on Recent Clinical Trials Targeting Cancer Stem Cells with Repurposed Drugs to Improve Current Therapies
Recent Patents on Anti-Cancer Drug Discovery Recent Advances in Controlled Release Pulmonary Therapy
Current Drug Delivery Phosphodiesterase 4 Inhibitors for the Treatment of Asthma and COPD
Current Medicinal Chemistry CD164 as a Basophil Activation Marker
Current Pharmaceutical Design Concurrent Use of Antiretrovirals and Anticonvulsants in Human Immunodeficiency Virus (HIV) Seropositive Patients
Current Pharmaceutical Design Physiology and Pharmacology of the Vanilloid Receptor
Current Neuropharmacology Meet Our Editorial Board Member:
Current Drug Metabolism Therapeutic Potential of Vanillin and its Main Metabolites to Regulate the Inflammatory Response and Oxidative Stress
Mini-Reviews in Medicinal Chemistry Hymenoptera Venom Proteins and Peptides for Diagnosis and Treatment of Venom Allergic Patients
Inflammation & Allergy - Drug Targets (Discontinued) Gene Therapy for Cystic Fibrosis Airway Disease- Is Clinical Success Imminent?
Current Gene Therapy Potential of Lung Surfactant Proteins, SP-A and SP-D, and Mannan Binding Lectin for Therapy and Genetic Predisposition to Allergic and Invasive Aspergillosis
Recent Patents on Inflammation & Allergy Drug Discovery Association between Gasdermin A, Gasdermin B Polymorphisms and Allergic Rhinitis Amongst Jordanians
Endocrine, Metabolic & Immune Disorders - Drug Targets Gene Therapy for Lung Diseases Development in the Vector Biology and Novel Concepts for Gene Therapy Applications
Current Molecular Medicine Immune Response, Diagnosis and Treatment of Allergic Bronchopulmonary Aspergillosis in Cystic Fibrosis Lung Disease
Current Pharmaceutical Design Targeting Lipoxygenases (LOs): Drug Design And Discovery
Current Enzyme Inhibition Therapeutical Potential of CB<sub>2</sub> Receptors in Immune-Related Diseases
Current Molecular Pharmacology Viral Encephalitis: Current Treatments and Future Perspectives
Central Nervous System Agents in Medicinal Chemistry